We are pleased to announce that a CSU Ventures startup company, Cetya Therapeutics was selected winner of the 2018 Venture Showcase Award presented by the Colorado Bioscience Association (CBSA) last month. The prestigious award identifies up and coming Colorado grown bioscience companies who have a compelling story and bright future.

Cetya Therapeutics is a Fort Collins based company developing targeted cancer drugs through the commercialization of largazole analogs designed to inhibit histone deacetylases, a class of enzymes known to be involved regulation of DNA, and in cancer. Cetya CEO, Cliff Hendrick, said, “Our team is energized to be named winner of the Colorado Life Science Innovation Forum Venture Showcase. The recognition gives our company additional momentum as we advance our oncology program.”

Todd Headley, President of CSU Ventures, the technology transfer office for the university, added, “We are thrilled that another CSU startup company has not only won the award but is placing Colorado at the forefront of advancing medicines to alleviate human disease.”

The Venture Showcase Award is presented every other year by CBSA at the Colorado Life Science Innovation Forum, and this is the third time a CSU startup company has received the award. Applications for the award come from both university and non-university founded bioscience companies.

Past CSU startup recipients of the award are SiVEC Biotechnologies (2016 winner) and VetDC (2012 winner). VetDC went on to develop Tanovea®-CA1, the first FDA-approved treatment for canine lymphoma, and is developing a second product, VDC-597, for treatment of additional canine cancers with high unmet need.  SiVEC is developing a technology to combat avian flu, and related flu virus outbreaks.  SiVEC was recently awarded a SBIR grant from National Institutes of Health, National Institute of Allergy and Infectious Diseases, to advance its patent-pending SiVEC-AIV antiviral technology.

We take pride in the successes of our startup companies and look to continually improve upon how we create and support companies based on CSU licensed technologies”, says Terry Opgenorth, PhD, VP CSU Ventures and Executive Director of CSUV’s LAUNCHAD program, “and look forward to bringing more companies to CBSA’s Innovation Forum in the future.”